Skip to main content
Clinical Trials/NCT02314013
NCT02314013
Unknown
Not Applicable

Prospective Randomized Clinical Trial for the Management of Uncomplicated Diverticulitis in Right Colon; Non-antibiotics Versus Antibiotics

Dongtan Sacred Heart Hospital1 site in 1 country132 target enrollmentApril 2014

Overview

Phase
Not Applicable
Intervention
Cephalosporin + Metronidazole
Conditions
Simple Diverticular Disease
Sponsor
Dongtan Sacred Heart Hospital
Enrollment
132
Locations
1
Primary Endpoint
Treatment Failure
Last Updated
9 years ago

Overview

Brief Summary

The aim of the present study was to evaluate whether antibiotics is mandatory for the treatment of acute uncomplicated right-sided diverticulitis.

The hypothesis is that patients having acute uncomplicated diverticulitis at right-sided colon will be recovered without antibiotics.

Detailed Description

All patients in the study were randomly allocated to one of the following two treatment groups; no-antibiotics group or antibiotics group. Patients of no-antibiotics group were admitted to the ward and administered intravenous fluid and bowel rest at least up to 5 days until clinical symptom and sign were stabilized. And then the patient discharge until oral intake was tolerated. In antibiotics group, the treatment was initiated with an intravenous combination of a third generation cephalosporin or quinolone and metronidazole until oral intake was tolerated. Oral antibiotics such as cefpodoxime together with metronidazole were initiated subsequently on the ward. The total duration of antibiotic treatment was an expected average 10days. Patients in both group were re-visited outpatient clinic after an expected average 7 days for check-up of serology test (including complete blood count and C-reactive protein), and after an expected average 6 weeks for CT. If the patients did not re-visit outpatient clinic, we checked the call.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
February 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dongtan Sacred Heart Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Right-sided colonic diverticulitis
  • Uncomplicated diverticulitis

Exclusion Criteria

  • Pregnancy
  • Refuse to investigation
  • Immunosuppressive therapy or immunologic incompetence
  • Colonic diverticulitis except right-sided diverticulitis
  • Complicated diverticulitis
  • Disorder of psychology or cognition
  • Allergic reaction to antibiotics being used in the study (3rd generation cephalosporin, quinolone, metronidazole)

Arms & Interventions

Cephalosporin + Metronidazole

intravenous antibiotics injection (3rd generation cephalosporin + metronidazole) and then change to oral antibiotics (3rd generation cephalosporin+ metronidazole) (an expected average 10 days)

Intervention: Cephalosporin + Metronidazole

Outcomes

Primary Outcomes

Treatment Failure

Time Frame: 4-6 weeks

advancement or recurrence diverticulitis at the same site.

Secondary Outcomes

  • total cost of hospitalization for diverticulitis(up to 2 weeks)
  • length of hospital stay at first admission for diverticulitis(up to 2 weeks)

Study Sites (1)

Loading locations...

Similar Trials